Mostrar el registro sencillo del ítem
Determinants of cancer immunotherapy success
| dc.creator | Karanikas, V. | en |
| dc.creator | Germenis, A. | en |
| dc.date.accessioned | 2015-11-23T10:33:20Z | |
| dc.date.available | 2015-11-23T10:33:20Z | |
| dc.date.issued | 2010 | |
| dc.identifier | 10.1586/erv.10.138 | |
| dc.identifier.issn | 1476-0584 | |
| dc.identifier.uri | http://hdl.handle.net/11615/29047 | |
| dc.source.uri | <Go to ISI>://WOS:000285487200003 | |
| dc.subject | cytolytic T lymphocytes | en |
| dc.subject | immunotherapy | en |
| dc.subject | pre-existing anti-tumor-specific | en |
| dc.subject | CTL | en |
| dc.subject | EX-VIVO CHARACTERIZATION | en |
| dc.subject | T-CELL RESPONSES | en |
| dc.subject | LUNG-CANCER | en |
| dc.subject | IMMUNOLOGICAL | en |
| dc.subject | EVALUATION | en |
| dc.subject | PEPTIDE VACCINATION | en |
| dc.subject | IMMUNOSENESCENCE | en |
| dc.subject | LYMPHOCYTES | en |
| dc.subject | FREQUENCY | en |
| dc.subject | MELANOMA | en |
| dc.subject | INDIVIDUALS | en |
| dc.subject | Immunology | en |
| dc.title | Determinants of cancer immunotherapy success | en |
| dc.type | journalArticle | en |
Ficheros en el ítem
| Ficheros | Tamaño | Formato | Ver |
|---|---|---|---|
|
No hay ficheros asociados a este ítem. |
|||